Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX)
CUSIP: 87164F105
Q2 2016 13F Holders as of 30 Jun 2016
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 86,328,130
- Total 13F shares
- 10,263,556
- Share change
- +1,108,355
- Total reported value
- $101,043,565
- Price per share
- $9.85
- Number of holders
- 46
- Value change
- +$10,817,957
- Number of buys
- 29
- Number of sells
- 10
Quarterly Holders Quick Answers
What is CUSIP 87164F105?
CUSIP 87164F105 identifies SNDX - Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 87164F105:
Top shareholders of SNDX - Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| MPM ASSET MANAGEMENT LLC |
13F
|
Company |
2.5%
|
2,168,691
|
$28,887,000 | — | 31 Mar 2016 | |
| FMR LLC |
13F
|
Company |
2.4%
|
2,094,464
|
$27,898,000 | — | 31 Mar 2016 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.5%
|
1,318,028
|
$17,557,000 | — | 31 Mar 2016 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.88%
|
757,365
|
$10,088,000 | — | 31 Mar 2016 | |
| EcoR1 Capital, LLC |
13F
|
Company |
0.59%
|
510,829
|
$6,804,000 | — | 31 Mar 2016 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.53%
|
460,892
|
$5,978,000 | — | 31 Mar 2016 | |
| BLACKROCK ADVISORS LLC |
13F
|
Company |
0.36%
|
308,693
|
$4,112,000 | — | 31 Mar 2016 | |
| TIVERTON ASSET MANAGEMENT LLC |
13F
|
Company |
0.33%
|
288,750
|
$3,846,000 | — | 31 Mar 2016 | |
| Redmile Group, LLC |
13F
|
Company |
0.3%
|
263,000
|
$3,503,000 | — | 31 Mar 2016 | |
| Boxer Capital, LLC |
13F
|
Company |
0.27%
|
234,220
|
$3,120,000 | — | 31 Mar 2016 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.25%
|
214,419
|
$2,856,000 | — | 31 Mar 2016 | |
| BlackRock Group LTD |
13F
|
Company |
0.21%
|
178,626
|
$2,379,000 | — | 31 Mar 2016 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.2%
|
175,000
|
$2,331,000 | — | 31 Mar 2016 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
0.17%
|
149,931
|
$1,997,000 | — | 31 Mar 2016 | |
| UNITED SERVICES AUTOMOBILE ASSOCIATION |
13F
|
Company |
0.07%
|
57,990
|
$772,000 | — | 31 Mar 2016 | |
| GENERAL ELECTRIC CO |
13F
|
Company |
0.06%
|
53,646
|
$715,000 | — | 31 Mar 2016 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.05%
|
47,114
|
$628,000 | — | 31 Mar 2016 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.05%
|
44,595
|
$594,000 | — | 31 Mar 2016 | |
| KORNITZER CAPITAL MANAGEMENT INC /KS |
13F
|
Company |
0.05%
|
40,000
|
$533,000 | — | 31 Mar 2016 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.03%
|
26,500
|
$353,000 | — | 31 Mar 2016 | |
| NORGES BANK |
13F
|
Company |
0.03%
|
25,000
|
$333,000 | — | 31 Mar 2016 | |
| BlackRock Investment Management, LLC |
13F
|
Company |
0.02%
|
18,086
|
$241,000 | — | 31 Mar 2016 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
3,479
|
$46,000 | — | 31 Mar 2016 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0%
|
2,989
|
$39,000 | — | 31 Mar 2016 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
863
|
$11,000 | — | 31 Mar 2016 | |
| BlackRock Institutional Trust Company, N.A. |
13F
|
Company |
0%
|
698
|
$9,000 | — | 31 Mar 2016 | |
| Catalyst Capital Advisors LLC |
13F
|
Company |
0%
|
182
|
$2,000 | — | 31 Mar 2016 |
Institutional Holders of Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) as of Q2 2016
As of 30 Jun 2016,
Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) was held by
46 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,263,556 shares.
The largest 10 holders included
MPM ASSET MANAGEMENT LLC, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Advisors LLC, ORBIMED ADVISORS LLC, JENNISON ASSOCIATES LLC, EcoR1 Capital, LLC, Redmile Group, LLC, Boxer Capital, LLC, and Cormorant Asset Management, LLC.
This page lists
46
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2016 vs Q1 2016 Across Filers
Q1 2016 holders
27
Q2 2016 holders
46
Holder diff
19
| Investor | Q1 2016 Shares | Q2 2016 Shares | Share Diff | Share Chg % | Q1 2016 Value $ | Q2 2016 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.